1. Home
  2. ASC vs BWAY Comparison

ASC vs BWAY Comparison

Compare ASC & BWAY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

ASC

Ardmore Shipping Corporation

HOLD

Current Price

$15.26

Market Cap

508.7M

ML Signal

HOLD

Logo BrainsWay Ltd.

BWAY

BrainsWay Ltd.

HOLD

Current Price

$13.94

Market Cap

450.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ASC
BWAY
Founded
2010
2003
Country
Bermuda
Israel
Employees
N/A
N/A
Industry
Marine Transportation
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
508.7M
450.8M
IPO Year
2013
N/A

Fundamental Metrics

Financial Performance
Metric
ASC
BWAY
Price
$15.26
$13.94
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
2
2
Target Price
$15.00
$13.25
AVG Volume (30 Days)
747.3K
151.4K
Earning Date
05-06-2026
03-11-2026
Dividend Yield
1.95%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$301.23
Revenue Next Year
N/A
$24.33
P/E Ratio
$16.60
$81.98
Revenue Growth
N/A
N/A
52 Week Low
$8.32
$7.84
52 Week High
$16.91
$26.63

Technical Indicators

Market Signals
Indicator
ASC
BWAY
Relative Strength Index (RSI) 54.53 33.52
Support Level $10.00 $11.55
Resistance Level $16.91 $14.65
Average True Range (ATR) 0.65 0.72
MACD -0.06 0.16
Stochastic Oscillator 66.04 68.49

Price Performance

Historical Comparison
ASC
BWAY

About ASC Ardmore Shipping Corporation

Ardmore Shipping Corp provides seaborne transportation of petroleum products and chemicals world-wide to oil majors, national oil companies, oil and chemical traders, and chemical companies, with its modern, fuel-efficient fleet of mid-size product and chemical tankers. The Company operates its business in one operating segment, the transportation of refined petroleum products and chemicals.

About BWAY BrainsWay Ltd.

BrainsWay Ltd is engaged in advanced noninvasive neurostimulation treatments for mental health disorders. The company is advancing neuroscience with its proprietary Deep Transcranial Magnetic Stimulation (Deep TMS) platform technology to improve health and transform lives. Current indications include depressive disorder (including reduction of anxiety symptoms, commonly referred to as anxious depression), obsessive-compulsive disorder, and smoking addiction. Additional clinical trials of Deep TMS in various psychiatric, neurological, and addiction disorders are underway. The company derives revenues from the lease and sale of Deep TMS systems.

Share on Social Networks: